Karim Mikhail
Chief Executive Officer chez Amarin Pharma, Inc.
Fortune : 957 156 $ au 31/03/2024
Profil
Karim Mikhail was the founder and former Chief Executive Officer of Theodon, which was founded in 2018.
He is currently the President and Chief Executive Officer of Amarin Pharma, Inc. Mr. Mikhail's former positions include President, Chief Executive Officer, and Director of Amarin Corp.
Plc from 2020 to 2023, and COO-Emerging Markets & CMO-Europe & Middle East at Merck & Co., Inc. Mr. Mikhail is a graduate of ESCP Europe Campus Paris.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
AMARIN CORPORATION
0,22% | 20/02/2024 | 790 742 ( 0,22% ) | 704 551 $ | 31/03/2024 |
| 21/02/2023 | 283 507 ( 0,07% ) | 252 605 $ | 31/03/2024 |
Postes actifs de Karim Mikhail
| Sociétés | Poste | Début |
|---|---|---|
Amarin Pharma, Inc.
 Amarin Pharma, Inc. Pharmaceuticals: MajorHealth Technology Amarin Pharma, Inc. operates as a biopharmaceutical research company. The company was founded in 2007 and is headquartered in Bedminster, NJ. | Chief Executive Officer | - |
Anciens postes connus de Karim Mikhail
| Sociétés | Poste | Fin |
|---|---|---|
| AMARIN CORPORATION PLC | Chief Executive Officer | 27/03/2023 |
| MERCK & CO., INC. | Chief Operating Officer | - |
| Theodon | Chief Executive Officer | - |
Formation de Karim Mikhail
| ESCP Europe Campus Paris | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| AMARIN CORPORATION PLC | Health Technology |
| Entreprise privées | 2 |
|---|---|
Amarin Pharma, Inc.
Amarin Pharma, Inc. Pharmaceuticals: MajorHealth Technology Amarin Pharma, Inc. operates as a biopharmaceutical research company. The company was founded in 2007 and is headquartered in Bedminster, NJ. | Health Technology |
| Theodon |
